Chargement en cours...

Aminoguanidine inhibits oxidative modification of low density lipoprotein protein and the subsequent increase in uptake by macrophage scavenger receptors.

Aminoguanidine decreases the formation of advanced glycosylation end products that occurs during chronic hyperglycemia. Presumably this occurs because early glycosylation products preferentially bind to aminoguanidine rather than to lysine groups of adjacent proteins. Because oxidative modification...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Picard, S, Parthasarathy, S, Fruebis, J, Witztum, J L
Format: Artigo
Langue:Inglês
Publié: 1992
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC49607/
https://ncbi.nlm.nih.gov/pubmed/1495978
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!